The von willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: A randomized trial

Stroke

Volumn 42, Issue 8, 2011, Pages 2149-2153

  Markus, Hugh S ^a   McCollum, Charles ^b   Imray, Chris ^c   Goulder, Michael A ^d   Gilbert, Jim ^e   King, Alice ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d Worldwide Clinical Trials   (United Kingdom)

^e Archimex Corp   (United States)

Author keywords

antiplatelet agents; antiplatelet drugs; antiplatelet RX; carotid endarterectomy; embolic stroke; embolism; transcranial Doppler

Indexed keywords

EGAPTIVON PEGOL; PLACEBO; VON WILLEBRAND FACTOR;

ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN PROTECTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL DETECTION; SURGICAL PATIENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APTAMERS, NUCLEOTIDE; CAROTID STENOSIS; DOUBLE-BLIND METHOD; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENTION TO TREAT ANALYSIS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PLATELET AGGREGATION; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 79961210182     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.616649     Document Type: Article

References (21)

1. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol. 2006;5:323-331.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
3. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-1673.
4. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233-2240. (Pubitemid 40632440)
5. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-969. (Pubitemid 47562312)
6. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489-497.
7. Geeganage C, Wilcox R, Bath PM. Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis. BMC Med. 2010;8:36.
8. Kleinschnitz C, De Meyer SF, Schwarz T, Austinat M, Vanhoorelbeke K, Nieswandt B, et al. Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood. 2009;113:3600-3603.
9. Gilbert JC, DeFeo-Fraulini T, Hutabarat RM, Horvath CJ, Merlino PG, Marsh HN, et al. First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation. 2007; 116:2678-2686. (Pubitemid 350291240)
10. Spiel AO, Mayr FB, Ladani N, Wagner PG, Schaub RG, Gilbert JC et al. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand factor mediated ex vivo platelet function in acute myocardial infarction. Platelets. 2009;20:334-340.
11. Markus HS, MacKinnon A. Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke. 2005;36:971-975. (Pubitemid 40629286)
12. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke. 2009;40:3711-3717.
13. Levi CR, O'Malley HM, Fell G, Roberts AK, Hoare MC, Royle JP, et al. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia. Brain. 1997;120:621-629. (Pubitemid 27174097)
14. Payne DA, Jones CI, Hayes PD, Thompson MM, London NJ, Bell PR, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004;109:1476-1481. (Pubitemid 38420174)
15. Kaposzta Z, Baskerville PA, Madge D, Fraser S, Martin JF, Markus HS. L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation. 2001;103:2371-2375. (Pubitemid 32448802)
16. Kaposzta Z, Martin JF, Markus HS. Switching off embolization from symptomatic carotid plaque using S-nitrosoglutathione. Circulation. 2002;105:1480-1484. (Pubitemid 34263281)
17. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke. 1998;29:725-729.
18. Markus HS, Molloy J. Use of a decibel threshold in detecting Doppler embolic signals. Stroke. 1997;28:692-695. (Pubitemid 27161447)
19. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat. 1982;10:1100-1120.
20. Markus HS, Brown MM. Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model. Stroke. 1993;24:1-5. (Pubitemid 23014372)
21. Lee JF, Stovall GM, Ellington AD. Aptamer therapeutics advance. Curr Opin Chem Biol. 2006;10:282-289. (Pubitemid 43815776)